CCL2 and diabetic kidney disease: Together with findings from previous studies, our results suggest that urine MCP-1 could be a promising biomarker for rapid GFR decline in DKD across a broad range of GFR, but additional studies are necessary to confirm the added benefit to conventional factors including UACR.